HUM - Humana Inc
237.96
| Index: | S&P 500 | P/E: | 16.83 | EPS (ttm): | 14.14 | Insider Own: | 0.22% | Shs Outstand: | 120.69M | Perf Week: | -4.64% |
| Market Cap: | 28.72B | Forward P/E: | 16.37 | EPS next Y: | 14.54 | Insider Trans: | 1.08% | Shs Float: | 120.43M | Perf Month: | -16.68% |
| Income(ttm): | 1.71B | PEG: | 1.55 | EPS next Q: | 5.97 | Inst Own: | 95.28% | Short Float: | 2.57% | Perf Quarter: | -6.25% |
| Revenue(ttm): | 120.26B | P/S: | 0.24 | EPS this Y: | 0.89% | Inst Trans: | 1.89% | Short Ratio: | 1.81 | Perf Half Y: | -15.03% |
| Book/sh: | 147.08 | P/B: | 1.62 | EPS next Y: | -11.09% | ROA: | 3.39% | Short Interest: | 3.09M | Perf Year: | -30.93% |
| Cash/sh: | - | P/C: | - | EPS next 5Y: | 10.84% | ROE: | 10.09% | 52W Range: | 212.45 - 406.46 | Perf YTD: | -6.21% |
| Dividend Est.: | 3.82 (1.61%) | P/FCF: | 12.06 | EPS past 5Y: | -13.05% | ROI: | 5.61% | 52W High: | -41.46% | Beta: | 0.42 |
| Dividend TTM: | 3.54 (1.49%) | Quick Ratio: | - | Sales past 5Y: | 12.71% | Gross Margin: | - | 52W Low: | 12.01% | ATR (14): | 11.06 |
| Dividend Ex-Date: | Jun 27, 2025 | Current Ratio: | 1.91 | EPS Y/Y TTM: | -12.18% | Oper. Margin: | 2.78% | RSI (14): | 39.62 | Volatility: | 5.01% 4.03% |
| Employees: | 65680 | Debt/Eq: | 0.75 | Sales Y/Y TTM: | 10.09% | Profit Margin: | 1.42% | Recom: | 2.44 | Target Price: | 297.91 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.72 | EPS Q/Q: | 68.47% | Payout: | 35.45% | Rel Volume: | 1.48 | Prev Close: | 227.47 |
| Sales Surprise: | -0.27% | EPS Surprise: | 14.97% | Sales Q/Q: | 8.45% | Earnings: | Apr 30 BMO | Avg Volume: | 1.71M | Price: | 237.96 |
| SMA20: | -5.61% | SMA50: | -9.08% | SMA200: | -16.12% | Undervalued: 25.19% | Volume: | 2,528,893 | Change: | 4.61% | |
Graham Classic formula value: 383.2
(P/E=8 * 1g) Min value: 239.21
(current P/E * 2g) Max value: 488.97
Average value: 370.46
About Humana Inc
Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.